Chris Newmarker
Executive Editor, Life Sciences at MassDevice
Executive Editor, Life Sciences at Medical Design & Outsourcing
Executive Editor, Life Sciences at Pharmaceutical Processing World
Executive Editor, Life Sciences at Drug Discovery & Development
Executive Editor, Life Sciences at Medical Tubing + Extrusion
A journalist for 18 years, I am executive editor of Life Sciences at WTWH Media. Media outlets include MassDevice, Medical Design & Outsourcing and more.
Articles
-
1 day ago |
pharmaceuticalprocessingworld.com | Chris Newmarker
Fujifilm Diosynth Biotechnologies, a major contract development and manufacturing organization (CDMO), has entered into a 10-year manufacturing supply agreement with Regeneron Pharmaceuticals, valued at over $3 billion. The deal has the Fujifilm subsidiary providing U.S.-based manufacturing for Regeneron, with planned expansions at Fujifilm’s large-scale biopharmaceutical manufacturing facility in Holly Springs, North Carolina.
-
1 day ago |
massdevice.com | Chris Newmarker
Imricor Medical Systems (ASX: IMR) recently announced that it has commenced its VISABL-VT clinical trial. A medical team at the Amsterdam University Medical Centre (AUMC) in the Netherlands completed the first-in-human ventricular ablation guided by real-time MRI with the company’s NorthStar Mapping System, Burnsville, Minnesota–based Imricor announced on April 16. According to Imricor, it was the first ventricular ablation and the first left-sided ablation performed with real-time MRI guidance.
-
1 day ago |
medicaldesignandoutsourcing.com | Chris Newmarker
The MIT Health and Life Sciences Collaborative recently announced the establishment of the Hood Pediatric Innovation Hub to drive children’s healthcare innovation. Launched in collaboration with the Boston-based Charles H. Hood Foundation — which has committed $15 million toward the effort over the next five years — the hub will focus on developing technologies and treatments tailored specifically for children, meeting unmet needs in pediatric medicine.
-
1 day ago |
massdevice.com | Chris Newmarker
Artedrone says preclinical studies show its Sasha microbotic system can autonomously perform mechanical thrombectomy for stroke treatment. Paris-based Artedrone, a Truffle Capital medtech portfolio company, said on April 17 that it has submitted results for publication in a research journal. Only a small percentage of people suffering from a stroke have access to a competent thrombectomy stroke center, according to Artredrone, which says its Sasha system can help address the problem.
-
2 days ago |
massdevice.com | Chris Newmarker
Augmedics announced today that it has treated 10,000 patients with its Xvision augmented reality spine surgery system. “Since inception, Augmedics has been a company of firsts — the first FDA-cleared AR navigation system for surgery, the first augmented reality spine surgeries in U.S., the first AR clinical accuracy studies,” Augmedics CEO Paul Ziegler said in a news release.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 2K
- Tweets
- 6K
- DMs Open
- No
According to Outset Medical, Inc., the FDA’s warning letter does not request the restriction of Tablo’s manufacturing, production or shipment in the U.S. It also does not request the withdrawal of the system from the U.S. market. S…https://t.co/MLauvwVNZR https://t.co/NJdmv6kHiU
#Medtech #meddevice industry #mergersandacquisitions continue. This time, Coloplast is buying. https://t.co/XgjNYEgaqZ
This move marks the second software-related buy in the past year for ResMed. #medtech #mergersandacquisitions #digitalhealth #sleepapnea #cpap https://t.co/p1UljWrAAL